WallStreetZenWallStreetZen

NASDAQ: LVTX
Lava Therapeutics Nv Stock Forecast, Predictions & Price Target

Analyst price target for LVTX

Based on 1 analyst offering 12 month price targets for Lava Therapeutics Nv.
Min Forecast
$6.00+112.01%
Avg Forecast
$6.00+112.01%
Max Forecast
$6.00+112.01%

Should I buy or sell LVTX stock?

Based on 1 analyst offering ratings for Lava Therapeutics Nv.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their LVTX stock forecasts and price targets.

LVTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-21

1 of 1

Forecast return on equity

Is LVTX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.66%

Forecast return on assets

Is LVTX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

LVTX revenue forecast

What is LVTX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$7.0M-6.93%
Avg 2 year Forecast
$4.5M-39.97%
Avg 3 year Forecast
$36.3M+382.59%
LVTX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LVTX revenue growth forecast

How is LVTX forecast to perform vs Biotechnology companies and vs the US market?
Company
-18.81%
Industry
37.96%
Market
10.23%
LVTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LVTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LVTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LVTX$2.83$6.00+112.01%Buy
VTVT$24.74N/AN/A
IFRX$1.26$13.50+971.43%Strong Buy
DTIL$10.72$60.00+459.70%Buy
ANEB$2.85N/AN/A

Lava Therapeutics Nv Stock Forecast FAQ

Is Lava Therapeutics Nv Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: LVTX) stock is to Buy LVTX stock.

Out of 1 analyst, 0 (0%) are recommending LVTX as a Strong Buy, 1 (100%) are recommending LVTX as a Buy, 0 (0%) are recommending LVTX as a Hold, 0 (0%) are recommending LVTX as a Sell, and 0 (0%) are recommending LVTX as a Strong Sell.

If you're new to stock investing, here's how to buy Lava Therapeutics Nv stock.

What is LVTX's revenue growth forecast for 2024-2028?

(NASDAQ: LVTX) Lava Therapeutics Nv's forecast annual revenue growth rate of -18.81% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.23%.

Lava Therapeutics Nv's revenue in 2024 is $7,357,608.On average, 1 Wall Street analysts forecast LVTX's revenue for 2024 to be $184,023,609, with the lowest LVTX revenue forecast at $184,023,609, and the highest LVTX revenue forecast at $184,023,609. On average, 2 Wall Street analysts forecast LVTX's revenue for 2027 to be $118,695,228, with the lowest LVTX revenue forecast at $103,316,112, and the highest LVTX revenue forecast at $134,074,344.

In 2028, LVTX is forecast to generate $954,188,702 in revenue, with the lowest revenue forecast at $685,093,607 and the highest revenue forecast at $1,480,864,271.

What is LVTX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: LVTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is LVTX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year LVTX price target, the average LVTX price target is $6.00, with the highest LVTX stock price forecast at $6.00 and the lowest LVTX stock price forecast at $6.00.

The Wall Street analyst predicted that Lava Therapeutics Nv's share price could reach $6.00 by Mar 21, 2025. The average Lava Therapeutics Nv stock price prediction forecasts a potential upside of 112.01% from the current LVTX share price of $2.83.

What is LVTX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: LVTX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.